Literature DB >> 33476017

Renal pH Mapping Using Chemical Exchange Saturation Transfer (CEST) MRI: Experimental Protocol.

Kowsalya Devi Pavuluri1, Lorena Consolino2, Dario Livio Longo3, Pietro Irrera4, Phillip Zhe Sun5,6,7, Michael T McMahon8,9.   

Abstract

Chemical exchange saturation transfer (CEST) is recognized as one of the premier methods for measuring pH with this environmental variable expected to be an excellent biomarker for kidney diseases. Here we describe step-by-step CEST MRI experimental protocols for producing pH and perfusion maps for monitoring kidney pH homeostasis in rodents after administering iopamidol as contrast agent. Several CEST techniques, acquisition protocols and ratiometric approaches are described. The impact of length of acquisition time on the quality of the maps is detailed. These methods may be useful for investigating progression in kidney disease in vivo for rodent models.This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network funded by the European Cooperation in Science and Technology (COST) program of the European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This experimental protocol is complemented by two separate chapters describing the basic concepts and data analysis.

Entities:  

Keywords:  Chemical exchange saturation transfer (CEST); Contrast agent; Iopamidol; Kidney; Magnetic resonance imaging (MRI); Mice; Rats; Responsive contrast agent; pH imaging

Year:  2021        PMID: 33476017     DOI: 10.1007/978-1-0716-0978-1_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Renal tubular acidosis.

Authors:  Helena Gil-Peña; Natalia Mejía; Fernando Santos
Journal:  J Pediatr       Date:  2013-12-15       Impact factor: 4.406

2.  The relationship between intracellular and extracellular pH in spontaneous canine tumors.

Authors:  D M Prescott; H C Charles; J M Poulson; R L Page; D E Thrall; Z Vujaskovic; M W Dewhirst
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

3.  Pathophysiology of Renal Tubular Acidosis: Core Curriculum 2016.

Authors:  Manoocher Soleimani; Asghar Rastegar
Journal:  Am J Kidney Dis       Date:  2016-05-14       Impact factor: 8.860

4.  MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.

Authors:  Annasofia Anemone; Lorena Consolino; Dario Livio Longo
Journal:  Eur Radiol       Date:  2016-08-29       Impact factor: 5.315

5.  Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.

Authors:  M L García-Martín; G Hérigault; C Rémy; R Farion; P Ballesteros; J A Coles; S Cerdán; A Ziegler
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

6.  Intracellular acidification of human melanoma xenografts by the respiratory inhibitor m-iodobenzylguanidine plus hyperglycemia: a 31P magnetic resonance spectroscopy study.

Authors:  R Zhou; N Bansal; D B Leeper; J D Glickson
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

Review 7.  Imaging pH and metastasis.

Authors:  Arig Ibrahim Hashim; Xiaomeng Zhang; Jonathan W Wojtkowiak; Gary V Martinez; Robert J Gillies
Journal:  NMR Biomed       Date:  2011-03-08       Impact factor: 4.044

8.  Quantitative description of radiofrequency (RF) power-based ratiometric chemical exchange saturation transfer (CEST) pH imaging.

Authors:  Renhua Wu; Dario Livio Longo; Silvio Aime; Phillip Zhe Sun
Journal:  NMR Biomed       Date:  2015-03-23       Impact factor: 4.044

9.  Measuring in vivo tumor pHe with CEST-FISP MRI.

Authors:  Vipul R Sheth; Yuguo Li; Liu Qi Chen; Christine M Howison; Chris A Flask; Mark D Pagel
Journal:  Magn Reson Med       Date:  2011-10-25       Impact factor: 4.668

10.  Perfusion imaging in renal diseases.

Authors:  N Grenier; F Cornelis; Y Le Bras; G Rigou; J R Boutault; M Bouzgarrou
Journal:  Diagn Interv Imaging       Date:  2013-10-14       Impact factor: 4.026

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.